1. Home
  2. News
  3. Inoviq Ltd
  4. INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
More Inoviq Ltd news
Inoviq LtdASX: IIQ

INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test

Mar 31, 2022 at 9:47 PM EDT · Issued by Inoviq Ltd

Filed with ASX · Mar 31, 2022 at 9:47 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/inoviq-and-uq-collaborate-on-exosome-based-ovarian-cancer-test

Inoviq Ltd on 6ix

Earlier from Inoviq

  • Update on Legal Proceedings and BARD1 Autoantibody ProgramMar 27, 2022
  • Brazilian Patent Issued for Lung & Colorectal CancerFeb 22, 2022
  • Appendix 4C & Quarterly Activities ReportJan 30, 2022
  • AGM PresentationNov 29, 2021
  • BARD1 Appoints New CSOSep 16, 2021

Later from Inoviq

  • INOVIQ Engages ResearchDX to Develop & Validate SubB2M-TestsApr 4, 2022
  • IIQ Appendix 4C & Quarterly Activities Report - March 2022Apr 29, 2022
  • INOVIQ Key Manufacturing Agreement to Advance SubB2M testsMay 1, 2022
  • Australian Patent Granted for SubB2M TechnologyMay 2, 2022
  • SubB2M US Patent Grant and Program UpdateJul 1, 2022
All Inoviq news releases↗

Follow Inoviq into a list and get an email when it puts out news.

Follow Inoviq
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer